Elzoghby AO - Search Results

1

Lactoferrin, a multi-functional glycoprotein: Active therapeutic, drug nanocarrier & targeting ligand.

Elzoghby AO, Abdelmoneem MA, Hassanin IA, Abd Elwakil MM, Elnaggar MA, Mokhtar S, Fang JY, Elkhodairy KA. Elzoghby AO, et al. Biomaterials. 2020 Dec;263:120355. doi: 10.1016/j.biomaterials.2020.120355. Epub 2020 Sep 9. Biomaterials. 2020. PMID: 32932142 Free PMC article. Review.

2

Lyophilization monophase solution technique for improvement of the physicochemical properties of an anticancer drug, flutamide.

Elgindy N, Elkhodairy K, Molokhia A, Elzoghby A. Elgindy N, et al. Eur J Pharm Biopharm. 2010 Feb;74(2):397-405. doi: 10.1016/j.ejpb.2009.11.011. Epub 2009 Nov 26. Eur J Pharm Biopharm. 2010. PMID: 19944160

3

Lyophilization monophase solution technique for preparation of amorphous flutamide dispersions.

Elgindy N, Elkhodairy K, Molokhia A, Elzoghby A. Elgindy N, et al. Drug Dev Ind Pharm. 2011 Jul;37(7):754-64. doi: 10.3109/03639045.2010.539232. Epub 2011 Jan 5. Drug Dev Ind Pharm. 2011. PMID: 21204753

4

Lyophilized flutamide dispersions with polyols and amino acids: preparation and in vitro evaluation.

Elgindy N, Elkhodairy K, Molokhia A, Elzoghby A. Elgindy N, et al. Drug Dev Ind Pharm. 2011 Apr;37(4):446-55. doi: 10.3109/03639045.2010.522190. Drug Dev Ind Pharm. 2011. PMID: 21446829

5

Biopolymeric microparticles combined with lyophilized monophase dispersions for controlled flutamide release.

Elgindy N, Elkhodairy K, Molokhia A, Elzoghby A. Elgindy N, et al. Int J Pharm. 2011 Jun 15;411(1-2):113-20. doi: 10.1016/j.ijpharm.2011.03.047. Epub 2011 Mar 30. Int J Pharm. 2011. PMID: 21457767

6

Natural Polymeric Nanoparticles for Brain-Targeting: Implications on Drug and Gene Delivery.

Elzoghby AO, Abd-Elwakil MM, Abd-Elsalam K, Elsayed MT, Hashem Y, Mohamed O. Elzoghby AO, et al. Curr Pharm Des. 2016;22(22):3305-23. doi: 10.2174/1381612822666160204120829. Curr Pharm Des. 2016. PMID: 26845323 Review.

7

Hybrid protein-inorganic nanoparticles: From tumor-targeted drug delivery to cancer imaging.

Elzoghby AO, Hemasa AL, Freag MS. Elzoghby AO, et al. J Control Release. 2016 Dec 10;243:303-322. doi: 10.1016/j.jconrel.2016.10.023. Epub 2016 Oct 26. J Control Release. 2016. PMID: 27794493 Review.

8

Protein-lipid nanohybrids as emerging platforms for drug and gene delivery: Challenges and outcomes.

Gaber M, Medhat W, Hany M, Saher N, Fang JY, Elzoghby A. Gaber M, et al. J Control Release. 2017 May 28;254:75-91. doi: 10.1016/j.jconrel.2017.03.392. Epub 2017 Mar 30. J Control Release. 2017. PMID: 28365294 Review.

9

Self-Assembled Nanocarriers Based on Amphiphilic Natural Polymers for Anti- Cancer Drug Delivery Applications.

Sabra S, Abdelmoneem M, Abdelwakil M, Mabrouk MT, Anwar D, Mohamed R, Khattab S, Bekhit A, Elkhodairy K, Freag M, Elzoghby A. Sabra S, et al. Curr Pharm Des. 2017;23(35):5213-5229. doi: 10.2174/1381612823666170526111029. Curr Pharm Des. 2017. PMID: 28552068 Review.

10

Zein-based Nanocarriers as Potential Natural Alternatives for Drug and Gene Delivery: Focus on Cancer Therapy.

Elzoghby A, Freag M, Mamdouh H, Elkhodairy K. Elzoghby A, et al. Curr Pharm Des. 2017;23(35):5261-5271. doi: 10.2174/1381612823666170622111250. Curr Pharm Des. 2017. PMID: 28641543 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

89 results

Search Page

Filters